Latest News

  • MARKET TRENDS

    19 Feb 2026

    AAV Arms Race: Who Controls Gene Therapy’s Future?

  • INNOVATION

    11 Feb 2026

    NanoMosaic Win Highlights Manufacturing’s New Frontier

  • MARKET TRENDS

    5 Feb 2026

    The Race to Modernize Viral Vector Production

  • PARTNERSHIPS

    3 Feb 2026

    Gene Therapy Grows Up as US Manufacturing Hits Its Stride

SMA Gets a Bigger Tool Kit as Gene Therapy Steps Up

Itvisma gene therapy packaging and vials used for spinal muscular atrophy treatment

INNOVATION

29 Nov 2025

Itvisma’s expanded FDA label opens treatment to older SMA patients and hints at broader gene therapy momentum

MIT campus building linked to gene therapy and viral vector research

INNOVATION

29 Oct 2025

Crystals That Could Change Gene Therapy

MIT's selective crystallization speeds AAV vector output, cuts costs, and signals a major shift in scalable gene therapy manufacturing

US biotech manufacturing lab expanding viral vector production capacity

INVESTMENT

8 Oct 2025

Investors Eye Carolina as Vector Capacity Expands

Oxford Biomedica’s new US vector site aims to ease shortages and speed gene therapy development

Matica Biotechnology manufacturing facility exterior in the United States

PARTNERSHIPS

16 Sep 2025

New Manufacturing Tie Up Could Lift Gene Therapy Timelines

Matica Bio partners with a clinical stage US biotech to expand vector supply and accelerate an undisclosed gene therapy candidate

AbbVie corporate signage displayed on an office building exterior

PARTNERSHIPS

20 Aug 2025

AbbVie Capstan Pact Powers In-Body Cell Push

AbbVie’s Capstan acquisition boosts interest in in body cell therapies while platforms remain unproven in the clinic

Gene therapy researcher analysing viral vector production data in a laboratory

TECHNOLOGY

29 Jul 2025

Small Digital Steps, Big Hopes for Gene Therapy Manufacturing

Gene therapy producers test data tools and intensified processes to improve viral vector quality and scale

FDA headquarters sign reflecting evolving US gene therapy regulation

REGULATORY

19 Jul 2025

How a Setback Could Shape the Next Era of Gene Therapy

FDA reverses a key vector designation, pushing developers toward tighter data and safer strategies

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.